Microenvironmental agonists generate phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL

about

CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma.Hematologic Tumor Cell Resistance to the BCL-2 Inhibitor Venetoclax: A Product of Its Microenvironment?

P2860

Q47549122-403414E4-F3B3-4410-A640-9BF46142227F Q58580676-373B9A53-06C3-48A3-BFB8-34BFCDCAE8B8

P2860

Microenvironmental agonists generate phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL

Item

http://www.wikidata.org/entity/Q56514276

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2017

@uk

name

Microenvironmental agonists ge ...... plus venetoclax in CLL and MCL

@en

Microenvironmental agonists ge ...... plus venetoclax in CLL and MCL

@nl

type

Item

label

Microenvironmental agonists ge ...... plus venetoclax in CLL and MCL

@en

Microenvironmental agonists ge ...... plus venetoclax in CLL and MCL

@nl

prefLabel

Microenvironmental agonists ge ...... plus venetoclax in CLL and MCL

@en

Microenvironmental agonists ge ...... plus venetoclax in CLL and MCL

@nl

P1476

Microenvironmental agonists ge ...... plus venetoclax in CLL and MCL

@en

P2093

Brian J Capaldo

http://www.w3.org/2001/XMLSchema#string

Craig A Portell

http://www.w3.org/2001/XMLSchema#string

Emanuel F Petricoin

http://www.w3.org/2001/XMLSchema#string

Julia D Wulfkuhle

http://www.w3.org/2001/XMLSchema#string

L Kyle Brett

http://www.w3.org/2001/XMLSchema#string

Mark J Axelrod

http://www.w3.org/2001/XMLSchema#string

Michael E Williams

http://www.w3.org/2001/XMLSchema#string

Michael J Weber

http://www.w3.org/2001/XMLSchema#string

Rosa I Gallagher

http://www.w3.org/2001/XMLSchema#string

Stefan Bekiranov

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-10 and the interleukin-10 receptor

Toll-like receptor signalling

Constitutive NF- κ B Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

P304

933-946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2016004176

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kallesh Danappa Jayappa

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29034364

http://www.w3.org/2001/XMLSchema#string

P932

5637393

http://www.w3.org/2001/XMLSchema#string